↓ Skip to main content

Biodistribution of Native and Nanoformulated Innate Defense Regulator Peptide 1002

Overview of attention for article published in Molecular Pharmaceutics, May 2024
Altmetric Badge

About this Attention Score

  • Good Attention Score compared to outputs of the same age (74th percentile)
  • Good Attention Score compared to outputs of the same age and source (67th percentile)

Mentioned by

twitter
11 X users

Readers on

mendeley
7 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Article details
Title
Biodistribution of Native and Nanoformulated Innate Defense Regulator Peptide 1002
Published in
Molecular Pharmaceutics, May 2024
DOI 10.1021/acs.molpharmaceut.3c01169
Pubmed ID
Authors

Login to access the Attention Digest and the Sentiment Analysis related to this output.

Timeline Attention over time Attention Score history
Login to access the full charts related to this output.
Activity
Login to access the full charts related to this output.
X Demographics

X Demographics

The data shown below were collected from the profiles of 11 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley demographics

Mendeley demographics

The data shown below were compiled from readership statistics for 7 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Login to view Mendeley reader trends over time.

Geographical breakdown

Geographical breakdown
Country Count As %
Unknown 7 100%

Demographic breakdown

Readers by professional status
Readers by professional status Count As %
Professor 1 14%
Student > Ph. D. Student 1 14%
Student > Master 1 14%
Unknown 4 57%
Readers by discipline
Readers by discipline Count As %
Chemical Engineering 1 14%
Agricultural and Biological Sciences 1 14%
Economics, Econometrics and Finance 1 14%
Unknown 4 57%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 6. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 03 June 2024.
All research outputs
#7,833,792
of 29,814,326 outputs
Outputs from Molecular Pharmaceutics
#1,130
of 4,854 outputs
Outputs of similar age
#90,492
of 351,659 outputs
Outputs of similar age from Molecular Pharmaceutics
#14
of 43 outputs
Altmetric has tracked 29,814,326 research outputs across all sources so far. This one has received more attention than most of these and is in the 73rd percentile.
So far Altmetric has tracked 4,854 research outputs from this source. They receive a mean Attention Score of 4.9. This one has done well, scoring higher than 76% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 351,659 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 74% of its contemporaries.
We're also able to compare this research output to 43 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 67% of its contemporaries.